Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-74.74	73.50	290.93
Graham Fair Price	132.11	60.20	25.93
PEG	1172.46	0.04	< 0.005
Price/Book	14.27	7.58	6.64
Price/Cash Flow	-62.09	148.76	392.35
Prices/Earnings	-65.87	13.01	38.12
Price/Sales	-14.48	37.38	43.71
Price/FCF	-62.09	148.76	392.35
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-9.05	0.76	0.84
Operating Margin	323.45	0.46	0.11
ROA	155.83	< 0.005	< 0.005
ROE	0.04	0.15	234.80
ROIC	0.02	0.05	119.30
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.38	-0.01	3148.20
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	2.31	6.27	171.39
EPS QOQ	121.00	3.25	-97.32
FCF QOQ	-0.64	2.87	350.94
Revenue QOQ	0.41	0.72	72.82
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	77319.04	100.00
Days Sales Outstanding (DSO)	40.14	61.43	53.03
Inventory Turnover	0.00	< 0.005	100.00
Debt/Capitalization	0.33	0.34	5.18
Quick Ratio	0.03	0.02	-27.42
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	26.21	33.24	26.85
Cash	26.34	29.61	12.40
Capex	-0.26	0.00	inf
Free Cash Flow	0.44	1.69	282.33
Revenue	3.98	6.74	69.51
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.03	1.02	-0.48
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-19.99	-2.94	85.30
Naive Interpretation	Member

06 - Financial Health · Bad

Rating